Global Expansion InClin operates in the United States and Australia with offices in the San Francisco Bay Area and Sydney, indicating a capability to manage multinational trials and engage sponsors seeking cross-region study execution and global regulatory alignment.

Full Service Expertise As a full-service CRO covering Phase 1 through Phase 4 plus QA, data management, biostatistics, drug safety, and strategic consulting, InClin can be a single vendor for sponsors looking to streamline vendor management and reduce CRO fragmentation.

Experienced Team Average staff experience of 20+ years and high employee retention suggest stable, expert trial execution teams, which can be a selling point to sponsors needing consistent performance and knowledge retention across study milestones.

Proven Track Record With over 100 pivotal Phase 2/3 studies, more than 400 trials and multiple NDA/BLA filings, InClin demonstrates reliability in delivering on time and on budget, appealing to sponsors with ambitious timelines and regulatory milestones.

Quality and Compliance Rigorous Quality Assurance framework aligned with FDA and EMA regulations combined with proactive sponsor communication positions InClin as a risk-mitigating partner for complex programs requiring stringent oversight and QA readiness.